The Institute for Peptide Therapy is an emerging European body convening clinicians, researchers and educators around peer exchange, professional education, clinical governance and the future of therapeutics. It will support the forthcoming Journal for Peptide Therapy, a monthly publication addressing clinically relevant advances from around the world.
Headquarters
European Union
Founders
Christopher Maclay, MD (Retired) & Tony Leto, JD
Status
In formation
Our remit
A considered space for clinicians and researchers to convene, compare practice and learn from one another.
Structured learning resources and continuing professional development for qualified practitioners.
Frameworks, standards and reflective tools that support safe, accountable and ethical practice.
Curating literature, supporting investigators and convening dialogue around emerging evidence.
A long-view forum for the scientific, regulatory and societal questions shaping the field.
A monthly editorial review of clinically relevant developments in peptide therapy, published under the Institute.
Education pathway
A structured postgraduate education pathway in therapeutic peptides, for healthcare professionals seeking an evidence-based understanding of one of the fastest-evolving areas of modern medicine. Programmes are organised around professional development — scientific integrity, clinical reasoning and the responsible governance of emerging therapies — rather than around individual compounds.
All programmes are delivered in English and suitable for an international audience. Additional language editions may follow.
Foundations in biology, pharmacology and pharmaceutical science
The scientific foundations of therapeutic peptides, without clinical implementation. Suitable for healthcare professionals, scientists, pharmacists, nurses, researchers and students wishing to understand peptide biology from first principles.
Clinical foundations and evidence-based reasoning
The intellectual framework that underpins all clinical education within the Institute. Rather than focusing on individual compounds, participants learn how experienced clinicians evaluate emerging therapies when the evidence is evolving.
A focused certificate exploring obesity, metabolic syndrome, insulin resistance, incretin biology and emerging metabolic therapies through current scientific evidence and clinical reasoning.
Coming soon →
Age-related anabolic decline, sarcopenia, muscle preservation and the physiology of healthy ageing.
Coming soon →
The biology of tissue healing, musculoskeletal recovery and regenerative mechanisms, examined through current evidence and clinical reasoning.
Coming soon →
Immune signalling, immunosenescence, inflammatory regulation and host defence — examined through current evidence and clinical reasoning.
Coming soon →
Biological ageing science, cellular senescence, longevity biology and the responsible evaluation of evidence in an unusually hype-prone field.
Coming soon →
Neuroplasticity, cognition, mood, sleep, neuroprotection and the careful evaluation of emerging neurological evidence.
Coming soon →
Clinical integration across domains
The Institute's most comprehensive educational programme. Participants complete the full sequence of foundation modules, clinical domains, governance training and integration assessment to develop a professional understanding of therapeutic peptides within contemporary healthcare. The programme explores the use of these therapies in an educational, non-promotional context.
Staying current as the evidence evolves
Learning in this field never stands still. The Institute will regularly release advanced online Masterclasses examining important developments in peptide science and clinical research.
Educational philosophy
Presenting evidence honestly, including its strengths and limitations.
Developing structured approaches to evaluating emerging therapies.
Emphasising governance, ethics and responsible professional practice.
Peptide science continues to evolve and requires continual critical appraisal.
Our programmes are educational in nature. They are designed to improve scientific understanding and professional knowledge. They do not provide prescribing advice or recommend the use of any specific medicinal product. Clinical decisions remain the responsibility of individual healthcare practitioners practising within their professional scope and applicable national laws.
A note on scope
This site is a placeholder while the Institute is being established. It is informational in nature and is not intended to promote, recommend or offer any therapy, product or clinical service.